$533M Generic Drug Price-Fixing Settlement Claims Open
Antitrust · Claims Open HOT
Generic Drug Price-Fixing Settlements: $533M in Sandoz, Sun/Taro, Heritage & Apotex Claims Open — File by November 9, 2026
PublishedJuly 13, 2026
If you or your health plan paid for common generic prescriptions between 2009 and 2019, you can now file a claim — and consumers do not need receipts or a Notice ID to do it.
What Are the Generic Drug Price-Fixing Settlements?
End-Payer Plaintiffs — consumers and third-party payers such as insurers and employers with self-funded
prescription drug plans — have reached a group of settlements in In re Generic Pharmaceuticals Pricing
Antitrust Litigation, the sprawling federal case (No. 2:16-MD-2724) pending before Judge Cynthia M. Rufe
in the U.S. District Court for the Eastern District of Pennsylvania. The lawsuit alleges that generic drug
manufacturers violated federal and state antitrust laws, consumer protection statutes, and common law by
coordinating to fix, raise, and stabilize prices, rig bids, and allocate customers for a long list of common
generic medications — causing end-payers to overpay.
The Court has granted final approval to three end-payer settlements that are now paying claims together:
$275 million with Sandoz Inc. and Fougera Pharmaceuticals Inc.; $200 million with Sun Pharmaceutical
Industries, Inc. and Taro Pharmaceuticals U.S.A., Inc.; and $58 million combined with Heritage
Pharmaceuticals Inc. (with Emcure Pharmaceuticals Ltd. and Satish Mehta) and Apotex Corp. — about
$533 million in total. The settling companies deny liability, and the litigation is continuing against the
remaining, non-settling defendants. A single claim deadline of November 9, 2026 applies across the
settlements.
StatusClaims OpenFinal approval granted · payments after distribution
Claim DeadlineNovember 9, 2026Submitted online or postmarked by mail
Proof RequiredNoConsumers self-attest — no Notice ID needed; keep pharmacy records. TPPs must submit transaction data (NDC, amounts paid, covered lives).
Who Qualifies?
You may be a Settlement Class member if you are a person or entity in any of the 50 United States — except
Indiana and Ohio — as well as the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, and you
indirectly purchased, paid, and/or provided reimbursement for some or all of the price of one or more of the
Named Generic Drugs, other than for resale, from May 1, 2009 through December 31, 2019.
The class splits into two groups. Consumers are individuals who bought one or more of the Named Generic Drugs
at a pharmacy or by mail order and paid all or part of the cost. Third-party payers (TPPs) are entities —
insurers, union benefit funds, and employers with self-funded prescription drug plans — that reimbursed some
or all of the cost on behalf of their members. Which settlements you can claim depends on which group you are
in:
• Consumers can file for the Sandoz and Sun/Taro settlements.
• Third-party payers can file for the Sandoz, Apotex, Heritage, and Sun/Taro settlements.
Several groups are excluded even if they otherwise fit — including the defendants and their affiliates,
federal governmental entities, state governmental entities (though cities, towns, counties, and other local
governments with self-funded prescription drug plans are included), governmental Medicaid agencies and
private Medicaid managed care organizations, pharmacy benefit managers, entities that only bought for resale
or directly from the defendants, and fully-insured employers to the extent they use fully-insured plans. The
Heritage and Apotex classes carry additional state-entity and date-range exclusions. If some of your
purchases qualify and others fall within an exclusion, you are in the class only for the qualifying
purchases. Anyone who validly excluded themselves from a settlement during its earlier opt-out window cannot
claim from that settlement.
Which Drugs Are Covered?
The settlements cover a list of roughly 200 Named Generic Drugs — many of the most commonly prescribed
generics in the country. Examples include albuterol, amitriptyline, baclofen, celecoxib, clobetasol,
clomipramine, digoxin, doxycycline, fluoxetine, gabapentin, glyburide, levothyroxine, pravastatin,
propranolol, verapamil, and warfarin, among many others. The complete list of Named Generic Drugs — and the
National Drug Code (NDC) numbers tied to them — is posted on the official settlement website. If a
medication you paid for during the class period is on that list, you may qualify.
How Much Can You Get?
There is no fixed per-person amount. After court-approved attorneys' fees, litigation expenses, service
awards, and administration costs are deducted, each settlement fund is distributed to class members on a pro
rata basis under a Court-approved Plan of Allocation — in proportion to how much you spent on the Named
Generic Drugs from May 1, 2009 through December 31, 2019. In general, those who spent more recover more, and
because the funds are split only among class members who file valid claims, a lower response rate can mean a
larger share for each claimant. You will not have to calculate your own payment; any accrued interest on the
funds is included pro rata. Payments go out after the Court authorizes distribution, likely in conjunction
with other settlements in the litigation.
How to File a Claim
You must submit a claim form so that it is filed online or postmarked by mail no later than
November 9, 2026. There are two claim types on the official site — a Consumer Claim (for individuals
filing on their own behalf) and a Third-Party Payer Claim (for the entity that paid for the drug).
• Consumers complete the form, sign it under penalty of perjury attesting they meet the
eligibility criteria, and submit it online or by U.S. Mail. No administrator-issued Notice ID or Claim ID is
required to file, but keep your own pharmacy or payment records in case the Claims Administrator asks you to
substantiate the claim.
• Third-party payers provide transaction-level data to support the claim — such as NDC numbers,
fill dates, state of service, amounts billed and paid net of co-pays and deductibles, and covered-lives
counts — and may be asked for additional documentation.
Submitting a claim does not guarantee a payment; if the Claims Administrator rejects or reduces a claim, you
will be notified and may use the dispute-resolution process described in the claim form. Class members do not
need to sign up with a claims-recovery firm or pay any other company to participate — you can file directly
and for free on the official settlement website.
Please note: The claims in this litigation are allegations. The settling manufacturers deny
liability and have not admitted any wrongdoing; the settlements resolve disputed claims without any
finding or admission that any law was broken. No trial has been held, and the case continues against the
remaining defendants.
Frequently Asked Questions
Who can file a claim in the generic drug price-fixing end-payer settlements?
Consumers and third-party payers (such as insurers and employers with self-funded prescription drug plans) in any of the 50 states except Indiana and Ohio, plus the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, who indirectly purchased, paid, or reimbursed for one or more of the Named Generic Drugs — other than for resale — from May 1, 2009 through December 31, 2019. Consumers can file for the Sandoz and Sun/Taro settlements; third-party payers can file for the Sandoz, Apotex, Heritage, and Sun/Taro settlements.
What is the claim deadline?
Claim forms must be submitted online or postmarked by mail no later than November 9, 2026. Late claims will not receive a payment.
How much money can I get?
There is no fixed amount. The settlement funds — about $533 million combined across the Sandoz ($275M), Sun/Taro ($200M), and Heritage/Apotex ($58M) settlements — are distributed on a pro rata basis in proportion to how much each class member spent on the Named Generic Drugs from May 1, 2009 through December 31, 2019, after court-approved fees, expenses, and administration costs are deducted. Those who spent more generally recover more, and if fewer class members file, each valid claim can receive a larger share.
Do I need proof or receipts to file?
Consumers file by completing the online or paper claim form and signing under penalty of perjury that they qualify — there is no administrator-issued Notice ID or Claim ID required to file, though you should keep your own pharmacy records in case the Claims Administrator requests them. Third-party payers must submit detailed transaction data (such as NDC numbers, fill dates, amounts paid, and covered-lives counts) to substantiate their claims.
Which drugs are covered?
The settlements cover a list of roughly 200 Named Generic Drugs — common medications such as albuterol, amitriptyline, celecoxib, clobetasol, clomipramine, digoxin, doxycycline, fluoxetine, gabapentin, glyburide, levothyroxine, pravastatin, and warfarin. The complete drug list and the associated National Drug Code (NDC) numbers are posted on the official settlement website.
Do I have to pay a claims-recovery firm to participate?
No. The settlement notice states that class members do not need to sign up with a claims-recovery firm or pay another company in order to participate. You can file directly and for free on the official settlement website.
Generic Drugs End-Payer & AG Overview: The full guide to the End-Payer classes and the separate State AG consumer refund program. Read the overview →
Generic Drugs Settlements — Complete Guide: Every settlement program, website, and claim process in the generic drugs price-fixing litigation. See the map →
$35M QVAR Inhaler Antitrust Settlement: Consumers & health plans that bought QVAR inhalers (Jan 2015 – Jul 2025) — claims open to July 31, 2026. Check eligibility →